Biology:Melatonin receptor 1B

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Melatonin receptor 1B, also known as MTNR1B, is a protein that in humans is encoded by the MTNR1B gene.[1][2]

Function

This gene encodes the MT2 protein, one of two high-affinity forms of a receptor for melatonin, the primary hormone secreted by the pineal gland. This gene product is an integral membrane protein that is a G-protein coupled, 7-transmembrane receptor. It is found primarily in the retina and brain; however, this detection requires RT-PCR. It is thought to participate in light-dependent functions in the retina and may be involved in the neurobiological effects of melatonin.[1] Besides the brain and retina this receptor is expressed on the bone forming cells where it regulates their function in depositing bone.[3]

Clinical significance

Several studies have identified MTNR1B receptor mutations that are associated with increased average blood sugar level and around a 20 percent elevated risk of developing type 2 diabetes.[4][5][6] MTNR1B mRNA is expressed in human islets, and immunocytochemistry confirms that it is primarily localized in beta cells in islets.[5]

Ligands

The following MT2R ligands have selectivity over MT1R:

  • Compound 3d: antagonist with sub-nM affinity[7]
  • Compound 18f: antagonist and compound 18g partial agonist: sub-nM affinity, >100-fold selectivity over MT1[8]
  • Compound 14: antagonist[9]
  • Compound 13: agonist[10]

See also

References

  1. 1.0 1.1 "Entrez Gene: MTNR1B melatonin receptor 1B". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4544. 
  2. "Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor". Proceedings of the National Academy of Sciences of the United States of America 92 (19): 8734–38. Sep 1995. doi:10.1073/pnas.92.19.8734. PMID 7568007. Bibcode1995PNAS...92.8734R. 
  3. "Regulation of bone mass through pineal-derived melatonin-MT2 pathway". J Pineal Res 79A (2): 263–270. 2006. doi:10.1111/jpi.12423. PMID 28512916. 
  4. "Gene That Regulates Glucose Levels And Increases Risk For Diabetes Identified". ScienceDaily. 2008-06-28. https://www.sciencedaily.com/releases/2008/06/080609085957.htm. ; "Body Clock Linked To Diabetes And High Blood Sugar In New Genome-wide Study". ScienceDaily. 2008-12-08. https://www.sciencedaily.com/releases/2008/12/081207133817.htm. ; "Is There A Relationship Between Sleep-wake Rhythm And Diabetes? A New Gene Variant Influences Fasting Glucose Levels Via The Melatonin Metabolism". ScienceDaily. 2009-01-16. https://www.sciencedaily.com/releases/2009/01/090116073601.htm. 
  5. 5.0 5.1 "Variants in MTNR1B influence fasting glucose levels". Nature Genetics 41 (1): 77–81. Jan 2009. doi:10.1038/ng.290. PMID 19060907. ; "Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion". Nature Genetics 41 (1): 82–88. Jan 2009. doi:10.1038/ng.288. PMID 19060908. ; "A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk". Nature Genetics 41 (1): 89–94. Jan 2009. doi:10.1038/ng.277. PMID 19060909. https://lirias.kuleuven.be/handle/123456789/242744. 
  6. Maedler, Kathrin, ed (2008). "Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function". PLOS ONE 3 (12): e3962. doi:10.1371/journal.pone.0003962. PMID 19088850. Bibcode2008PLoSO...3.3962S. 
  7. "N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands". Journal of Medicinal Chemistry 50 (26): 6618–26. Dec 2007. doi:10.1021/jm700957j. PMID 18052314. 
  8. "Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands". Journal of Medicinal Chemistry 49 (25): 7393–403. Dec 2006. doi:10.1021/jm060850a. PMID 17149869. 
  9. "Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands". Bioorganic & Medicinal Chemistry 11 (5): 753–59. Mar 2003. doi:10.1016/S0968-0896(02)00473-X. PMID 12538005. 
  10. "Indanyl piperazines as melatonergic MT2 selective agents". Bioorganic & Medicinal Chemistry Letters 13 (6): 1199–202. Mar 2003. doi:10.1016/S0960-894X(03)00090-8. PMID 12643943. 

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.